Safety profile of parenteral meglumine antimoniate (Glucantime®) in infants treated for cutaneous leishmaniasis

被引：0
|
作者：
Frikha, Fatma [1 ]
Boudaya, Sonia [1 ]
Bahloul, Emna [1 ]
Amouri, Meriem [1 ]
Turki, Hamida [1 ]
机构：
[1] Hop Hedi Chaker, Serv Dermatol Venereol, Ave Ain, Sfax 3089, Tunisia
来源：
THERAPIE | 2020年 / 75卷 / 03期
关键词：
Cutaneous leishmaniasis; Glucantime; Meglumine antimoniate; Side effects; Infant; Children; HIGH-FREQUENCY; CHILDREN; PHARMACOKINETICS;
D O I：
10.1016/j.therap.2019.05.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：314 / 316
页数：4
相关论文
共 50 条
  • [21] Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate
    Cruz, Adriana
    Rainey, Petrie M.
    Herwaldt, Barbara L.
    Stagni, Grazia
    Palacios, Ricardo
    Trujillo, Rodolfo
    Saravia, Nancy G.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (04): : 602 - 608
  • [22] Factors associated with treatmet failure of cutaneous leishmaniasis with meglumine antimoniate
    Rodrigues, AM
    Hueb, M
    dos Santos, TARR
    Fontes, CJF
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2006, 39 (02) : 139 - 145
  • [23] Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
    Sorkhroodi, F. Zamani
    Naeini, A. M. Alavi
    Ramazani, A. R. Zahraei
    Ghazvini, M. R. Aghaye
    Mohebali, M.
    Keshavarz, S. A.
    [J]. IRANIAN JOURNAL OF PARASITOLOGY, 2010, 5 (03) : 11 - 19
  • [24] Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in Children
    Consuelo Rubiano, Luisa
    Consuelo Miranda, Maria
    Muvdi Arenas, Sandra
    Mery Montero, Luz
    Rodriguez-Barraquer, Isabel
    Garcerant, Daniel
    Prager, Martin
    Osorio, Lyda
    Ximena Rojas, Maria
    Perez, Mauricio
    Santiago Nicholls, Ruben
    Gore Saravia, Nancy
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (04): : 684 - 692
  • [25] Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of Old World cutaneous leishmaniasis
    Munir, Abrar
    Janjua, Shahbaz A.
    Hussain, Ijaz
    [J]. ACTA DERMATOVENEROLOGICA CROATICA, 2008, 16 (02) : 60 - 64
  • [26] CUTANEOUS LEISHMANIASIS - TREATMENT WITH CRYOTHERAPY AND INTRAMUSCULAR INJECTIONS OF MEGLUMINE ANTIMONATE (GLUCANTIME)
    RZANY, B
    KRUTMANN, J
    GOERTTLER, E
    SCHOPF, E
    [J]. HAUTARZT, 1990, 41 (02): : 98 - 101
  • [27] Effectiveness and safety of intralesional treatment with meglumine antimoniate in patients with the cutaneous presentation of American tegumentary leishmaniasis
    Ferreira e Vasconcellos, Erica de Camargo
    Fernandes Pimentel, Maria Ines
    Valete-Rosalino, Claudia Maria
    Lyra, Marcelo Rosandiski
    Salgueiro, Mariza de Matos
    Saheki, Mauricio Naoto
    Madeira, Maria de Fatima
    Comfort, Eliame Mouta
    Conceicao-Silva, Fatima
    Schubach, Armando de Oliveira
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2010, 43 : 52 - 55
  • [28] Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate
    Faghihi, G
    Tavakoli-kia, R
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (01) : 13 - 16
  • [29] Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis
    Moosavi, Z
    Nakhli, A
    Rassaii, S
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2005, 44 (12) : 1064 - 1065
  • [30] Intralesional injections of metronidazole versus meglumine antimoniate for the treatment of cutaneous leishmaniasis
    Mapar, Mohammad Ali
    Omidian, Mohammad
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2010, 3 (02) : 79 - 83
12345